History
  • No items yet
midpage
897 F.3d 825
7th Cir.
2018
Read the full case

Background

  • Cochran, a small Georgia pharmaceutical distributor, sent unsolicited marketing faxes to ~17,000 businesses; Camp Drug Store and ARCare sued as class representatives under the TCPA.
  • Parties mediated early (before substantive litigation or discovery) and reached a claims-made settlement: Cochran would make up to $700,000 available for claims; unclaimed funds would revert to Cochran.
  • Claimants could submit forms for $125 each; 1,765 claims were submitted and Cochran paid $220,625 to claimants.
  • Settlement contemplated up to $233,333.33 (one-third of $700,000) for class counsel and $15,000 incentive awards to each named plaintiff; Cochran did not object to the requested amounts but did not guarantee payment beyond court award.
  • The district court preliminarily approved but expressed concerns about (1) lack of discovery/early-stage settlement, (2) reversion of unclaimed funds, and (3) magnitude of fee and incentive requests relative to work done.
  • At final approval, the district court concluded the arrangement was a "claims-made" settlement (not a common fund), awarded fees equal to 33.3% of the amount actually paid to claimants ($73,468.13), and reduced each incentive award to $1,000. Camp Drug Store appealed.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the $700,000 pledge constituted a common fund for fee calculation The settlement created a common fund; Boeing requires fees be measured against the fund available (one-third of $700,000) The arrangement was claims-made with reversion; no sum certain was surrendered to the class Settlement was not a common fund; district court correctly treated it as claims-made
Whether the requested attorney fee (one-third of $700,000) was reasonable One-third of the settlement fund is customary; Boeing supports measuring fees against the fund Fee was disproportionate to the work done given early-stage settlement and scarce litigation activity Court reasonably reduced fee to one-third of actual recovery (33.3% of $220,625) given limited work and market considerations
Appropriate method to assess reasonableness of fees in such settlements Use percentage-of-fund approach tied to available fund Compare fees to actual recovery and lodestar cross-check considering risk and work performed District court properly considered market price, lodestar as cross-check, and compared fees to amount actually paid to class; no abuse of discretion
Whether $15,000 incentive awards were appropriate $15,000 is commensurate with awards in other TCPA cases Named plaintiffs’ participation was minimal; $15,000 was excessive District court reasonably reduced incentive awards to $1,000 each based on limited time/effort; affirmed

Key Cases Cited

  • Boeing Co. v. Van Gemert, 444 U.S. 472 (1980) (common-fund doctrine: attorneys who create a common fund are entitled to reasonable fees assessed against the fund)
  • Holtzman v. Turza, 728 F.3d 682 (7th Cir. 2013) (TCPA class actions often stem from discrete injuries and may not create a common fund)
  • Holtzman v. Turza, 828 F.3d 606 (7th Cir. 2016) (follow-up framing TCPA claims as individual rather than common-fund injuries)
  • Isby v. Bayh, 75 F.3d 1191 (7th Cir. 1996) (factors for evaluating fairness of class settlements)
  • Reynolds v. Beneficial Nat’l Bank, 288 F.3d 277 (7th Cir. 2002) (district judge’s fiduciary role in settlement-phase review)
  • Redman v. RadioShack Corp., 768 F.3d 622 (7th Cir. 2014) (limits on including administrative costs in the fee-vs-class-recovery comparison)
Read the full case

Case Details

Case Name: Camp Drug Store, Incorporated v. Cochran Wholesale Pharmaceutic
Court Name: Court of Appeals for the Seventh Circuit
Date Published: Jul 27, 2018
Citations: 897 F.3d 825; 17-2086
Docket Number: 17-2086
Court Abbreviation: 7th Cir.
Log In